Oncology
Oncology APIs
| Product | Therapeutic Use | Regulatory / Grade |
|---|---|---|
| Axitinib | Anti-Cancer / TKI | USDMF |
| Azacitidine | Anti-Cancer | USDMF |
| Bendamustine HCl Monohydrate | Anti-Cancer | USDMF |
| Bicalutamide | Anti-Cancer | USDMF |
| Bortezomib | Anti-Cancer | IP / USDMF |
| Busulfan | Anti-Cancer | CEP, USDMF |
| Cabazitaxel | Anti-Cancer | USDMF |
| Calcium Folinate | Anti-Cancer (adjunct) | USP/BP/EP/IP |
| Capecitabine | Anti-Cancer | CEP, USDMF |
| Carboplatin | Anti-Cancer | USP/Ph.Eur/BP |
| Carmustine | Anti-Cancer | USP/Ph.Eur/BP |
| Chlorambucil | Anti-Cancer | USP/BP/EP/IP |
| Cisplatin | Anti-Cancer | USP/Ph.Eur/BP/IP |
| Clofarabine | Anti-Cancer | USDMF |
| Crizotinib | Anti-Cancer | In-house |
| Cyclophosphamide | Anti-Cancer | USDMF, CEP |
| Product | Therapeutic Use | Regulatory / Grade |
|---|---|---|
| Fulvestrant | Anti-Cancer | USP/IP |
| Gemcitabine HCl | Anti-Cancer | CEP, USDMF |
| 5-Fluorouracil | Anti-Cancer | USP/BP/EP/IP |
| Ibrutinib | Anti-Cancer / BTK inhibitor | USDMF |
| Imatinib Mesylate | Anti-Cancer | CEP, USDMF |
| Irinotecan HCl Trihydrate | Anti-Cancer | CEP, USDMF |
| Lenalidomide | Anti-Cancer | USDMF |
| Lenvatinib Mesylate | Anti-Cancer | USDMF |
| Melphalan / Melphalan HCl | Anti-Cancer | IP/USP, USDMF |
| Methotrexate | Anti-Cancer | USP/Ph.Eur/BP/IP |
| Mitomycin | Anti-Cancer | USP/BP/EP/IP |
| Nilutamide | Anti-Cancer | Ph.Eur |
| Oxaliplatin | Anti-Cancer | USP/Ph.Eur/BP |
| Paclitaxel | Anti-Cancer | USP/Ph.Eur/BP/IP |
| Palbociclib (N-1/N-2) | Anti-Cancer | Advanced Intermediate |
| Pemetrexed Disodium | Anti-Cancer | USP, USDMF |
| Product | Therapeutic Use | Regulatory / Grade |
|---|---|---|
| Zoledronic Acid | Anti-Cancer / Bone | IP, USDMF |
| Cytarabine | Anti-Cancer | USP/Ph.Eur/BP/IP |
| Dasatinib (incl. Monohydrate) | Anti-Cancer | DMF Available / In-house |
| Decitabine | Anti-Cancer | USDMF |
| Docetaxel Trihydrate | Anti-Cancer | USP/Ph.Eur/IP/BP |
| Enzalutamide | Anti-Cancer | USDMF |
| Erlotinib HCl | Anti-Cancer | USDMF |
| Etoposide | Anti-Cancer | USP/Ph.Eur/BP/IP |
| Fludarabine Phosphate | Anti-Cancer | Ph.Eur/In-house |
| Pomalidomide | Anti-Cancer | USDMF |
| Sunitinib Malate | Anti-Cancer | USDMF |
| Temozolomide | Anti-Cancer | USP/IP, CEP, USDMF |
| Thalidomide | Anti-Cancer | USDMF |
| Trofosfamide | Anti-Cancer | In-house |
| Vinblastine Sulphate | Anti-Cancer | USP/Ph.Eur/BP/IP |
| Vincristine Sulphate | Anti-Cancer | USP/Ph.Eur/IP |
| Vinorelbine Tartrate | Anti-Cancer | USP/Ph.Eur/BP/IP |